Get the Stockscreener App
43.73
0.57%
-0.25
After Hours:
43.79
0.06
+0.14%
Spdr Pharmaceuticals Etf stock is traded at $43.73, with a volume of 24,915.
It is down -0.57% in the last 24 hours and down -2.08% over the past month.
See More
Previous Close:
$43.98
Open:
$44.19
24h Volume:
24,915
Relative Volume:
0.51
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.36%
1M Performance:
-2.08%
6M Performance:
+4.04%
1Y Performance:
+4.89%
1-Day Range:
$43.72
$44.19
1-Week Range:
$42.63
$44.19
52-Week Range:
$38.88
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Name
Spdr Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
43.73 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
296.20 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
597.58 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
600.26 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.52 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
521.74 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Stock (XPH) Latest News
JPMorgan Chase & Co. Acquires 530 Shares of SPDR Dow Jones REIT ETF (NYSEARCA:RWR) - Defense World
JPMorgan Chase & Co. Sells 47,417 Shares of SPDR Portfolio Corporate Bond ETF (NYSEARCA:SPBO) - Defense World
How To Trade (XPH) - Stock Traders Daily
Healthcare executives weigh policy unknowns at San Francisco gathering - Financial Times
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Sold by Jane Street Group LLC - Defense World
6 Best Health Care ETFs to Buy for 2025 | Investing - U.S News & World Report Money
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Principal Financial Group Inc. Has $1.53 Million Position in SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK) - Defense World
7 Best-Performing Biotech ETFs for January 2025 - NerdWallet
(XPH) Proactive Strategies - Stock Traders Daily
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - MSN
Stifel Financial Corp Invests $337,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Stifel Financial Corp Buys Shares of 14,687 Franklin High Yield Corporate ETF (BATS:FLHY) - Defense World
Stifel Financial Corp Has $353,000 Position in JPMorgan International Bond Opportunities ETF (BATS:JPIB) - Defense World
XHE: 3 Healthcare ETFs for Defensive Investing - StockNews.com
3 Healthcare Stocks to Buy for a 2025 Rebound - Barron's
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1548 - MSN
Learn to Evaluate (XPH) using the Charts - Stock Traders Daily
Stifel Financial Corp Sells 174 Shares of SPDR S&P Capital Markets ETF (NYSEARCA:KCE) - Defense World
Teva Smashes $20 Resistance: Bullish Momentum Builds After UC Drug Success - Money Morning
SPDR Barclays 1-10 Year TIPS ETF declares monthly distribution of $0.0424 - MSN
(XPH) Trading Report - Stock Traders Daily
XBI: 3 Biotech ETFs for Diversified Innovation Exposure - StockNews.com
Objective long/short (XPH) Report - Stock Traders Daily
Here's Why a Handful of Pharmaceutical Stocks Rose Wednesday - MSN
Top 5 Life Science ETFs in 2024 - Investing News Network
XLV: 3 Healthcare ETFs to Buy for Defensive Growth - StockNews.com
Pharma stocks fall as Trump picks vaccine skeptic Robert F. Kennedy Jr. for US health job - USA TODAY
Drugmaker shares drop after RFK Jr. tapped to lead HHS - The Hill
What Are Wall Street Analysts' Target Price for Zoetis Stock? - Inkl
Global Pharma carries the most overweight allocations in Nov – according to BofA’s Global FMS - MSN
(XPH) Long Term Investment Analysis - Stock Traders Daily
Barrick Gold Corp (GOLD-N) QuotePress Release - The Globe and Mail
Boeing Company (BA-N) QuotePress Release - The Globe and Mail
Johnson & Johnson (JNJ-N) QuotePress Release - The Globe and Mail
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink? - MSN
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
Select Sector SPDR ETFs Offer Targeted Investment Opportunities Across Economic Sectors - Citybuzz
Should You Invest in the Financial Select Sector SPDR ETF (XLF)? - Yahoo Finance
(XPH) Investment Analysis and Advice - Stock Traders Daily
Best Biotech ETFs to Watch Right Now - The Motley Fool
Healthcare bankruptcies slow after peaking in 2023: report - MSN
Here's exactly how to prepare for a Trump or Harris presidency — and how to build a 5-part 'election-proof portfolio' - Business Insider
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike - MSN
What's the State of the Market? We'll Let the Charts Do the Talking - TheStreet
The Technology Select Sector SPDR Fund (XLK) Stock Price, News, Quote & History - Yahoo Finance
Should You Invest in the Industrial Select Sector SPDR ETF (XLI)? - Yahoo Finance
How to Take Advantage of moves in (XPH) - Stock Traders Daily
Commonwealth Equity Services LLC Acquires 602 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Hancock Whitney Corp Acquires 1,440 Shares of SPDR S&P Emerging Markets SmallCap ETF (NYSEARCA:EWX) - Defense World
The Energy Select Sector SPDR Fund (XLE) Stock Price, News, Quote & History - Yahoo Finance
Spdr Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for Spdr Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):